4//SEC Filing
Harris Erik 4
Accession 0001209191-23-038885
CIK 0001515673other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:17 PM ET
Size
5.1 KB
Accession
0001209191-23-038885
Insider Transaction Report
Form 4
Harris Erik
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-19$48.20/sh−305$14,701→ 57,281 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- [F2]Includes 242 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001780113
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:17 PM ET
- Size
- 5.1 KB